Serum tumor necrosis factor in patients with gastric cancer

Chew Wun Wu; Chin Wen Chi; Mao Chih Hsieh; Miao Fen Chao; Wing Yiu Lui; Fang Ku P'Eng

Serum tumor necrosis factor in patients with gastric cancer

Chew Wun Wu, Chin Wen Chi, Mao Chih Hsieh, Miao Fen Chao, Wing Yiu Lui, Fang Ku P'Eng

Taipei Municipal Wanfang Hospital

Research output: Contribution to journal › Article › peer-review

16 Citations (Scopus)

Abstract

We have measured serum TNF-α levels in 220 gastric cancer patients, 9 patients with gastric polyps or ulcers, 9 hepatitis B carriers and 85 normal controls. The results showed that no postitive TNF-α value ( > 10 pg/ml) was detected in Hepatitis B carriers and benign gastric lesions' patients and normal controls. In the cancer group, 17 out of 220 patients (7.7%) had positive-TNF-α values. The proportion of TNF-α positive was 6.8% in stage I disease, 6.5% in stage ll disease, 3.7% stage III, and 12.9% stage IV. No clinicopathologic factors were related to positive TNF-α value. TNF-α value was not an indenendent prognostic indicator. The role of TNF-α in gastric cancer remains obscures.

Original language	English
Pages (from-to)	1597-1599
Number of pages	3
Journal	Anticancer Research
Volume	18
Issue number	3 A
Publication status	Published - May 1998

Keywords

Gastric cancer
TNF-α

ASJC Scopus subject areas

Cancer Research
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{733d856d0d3b4e998c3f5049e105ea3c,

title = "Serum tumor necrosis factor in patients with gastric cancer",

abstract = "We have measured serum TNF-α levels in 220 gastric cancer patients, 9 patients with gastric polyps or ulcers, 9 hepatitis B carriers and 85 normal controls. The results showed that no postitive TNF-α value ( > 10 pg/ml) was detected in Hepatitis B carriers and benign gastric lesions' patients and normal controls. In the cancer group, 17 out of 220 patients (7.7%) had positive-TNF-α values. The proportion of TNF-α positive was 6.8% in stage I disease, 6.5% in stage ll disease, 3.7% stage III, and 12.9% stage IV. No clinicopathologic factors were related to positive TNF-α value. TNF-α value was not an indenendent prognostic indicator. The role of TNF-α in gastric cancer remains obscures.",

keywords = "Gastric cancer, TNF-α",

author = "Wu, {Chew Wun} and Chi, {Chin Wen} and Hsieh, {Mao Chih} and Chao, {Miao Fen} and Lui, {Wing Yiu} and P'Eng, {Fang Ku}",

year = "1998",

month = may,

language = "English",

volume = "18",

pages = "1597--1599",

journal = "Anticancer Research",

issn = "0250-7005",

publisher = "International Institute of Anticancer Research",

number = "3 A",

}

TY - JOUR

T1 - Serum tumor necrosis factor in patients with gastric cancer

AU - Wu, Chew Wun

AU - Chi, Chin Wen

AU - Hsieh, Mao Chih

AU - Chao, Miao Fen

AU - Lui, Wing Yiu

AU - P'Eng, Fang Ku

PY - 1998/5

Y1 - 1998/5

N2 - We have measured serum TNF-α levels in 220 gastric cancer patients, 9 patients with gastric polyps or ulcers, 9 hepatitis B carriers and 85 normal controls. The results showed that no postitive TNF-α value ( > 10 pg/ml) was detected in Hepatitis B carriers and benign gastric lesions' patients and normal controls. In the cancer group, 17 out of 220 patients (7.7%) had positive-TNF-α values. The proportion of TNF-α positive was 6.8% in stage I disease, 6.5% in stage ll disease, 3.7% stage III, and 12.9% stage IV. No clinicopathologic factors were related to positive TNF-α value. TNF-α value was not an indenendent prognostic indicator. The role of TNF-α in gastric cancer remains obscures.

AB - We have measured serum TNF-α levels in 220 gastric cancer patients, 9 patients with gastric polyps or ulcers, 9 hepatitis B carriers and 85 normal controls. The results showed that no postitive TNF-α value ( > 10 pg/ml) was detected in Hepatitis B carriers and benign gastric lesions' patients and normal controls. In the cancer group, 17 out of 220 patients (7.7%) had positive-TNF-α values. The proportion of TNF-α positive was 6.8% in stage I disease, 6.5% in stage ll disease, 3.7% stage III, and 12.9% stage IV. No clinicopathologic factors were related to positive TNF-α value. TNF-α value was not an indenendent prognostic indicator. The role of TNF-α in gastric cancer remains obscures.

KW - Gastric cancer

KW - TNF-α

UR - http://www.scopus.com/inward/record.url?scp=0031854673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031854673&partnerID=8YFLogxK

M3 - Article

C2 - 9673376

AN - SCOPUS:0031854673

SN - 0250-7005

VL - 18

SP - 1597

EP - 1599

JO - Anticancer Research

JF - Anticancer Research

IS - 3 A

ER -

Serum tumor necrosis factor in patients with gastric cancer

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Other files and links

Fingerprint

Cite this